Skip to content

Bristol-Myers Squibb BMY Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin281.3%0.0pp281.3%0.0pp281.3%-5.4pp286.7%-5.1pp291.8%-5.2pp
Net margin52.5%+3.8pp48.7%+33.3pp15.4%+27.7pp-12.3%+24.5pp-36.8%+24.7pp
Returns
Return on equity141.7%+7.3pp134.4%+79.9pp54.5%+64.9pp-10.4%+55.6pp-66%+57.0pp
Return on invested capital44.5%+4.2pp40.2%+27.2pp13%+22.0pp-9%+18.5pp-27.5%+18.1pp
Efficiency
Asset turnover2.1×0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio5.1×+0.1×0.0×0.0×+0.1×4.9×+0.2×
Leverage
Debt-to-equity10.3×-0.6×10.9×-0.6×11.5×-0.3×11.7×-0.3×12×-0.5×
Net debt / EBITDA10.9×-0.1×11×-36.3×47.3×-10.1×57.4×-10.0×67.4×-8.8×
Valuation
Market capitalization$421.15B-0.1%$421.42B-1.2%$426.32B-3.0%$439.42B+2.7%$427.9B+3.5%
Price / earnings67.2×-6.2×73.4×
Price / sales8.8×-0.1×8.8×-0.1×8.9×-0.3×9.2×+0.2×+0.2×
Price / book22.6×-1.0×23.5×-1.1×24.6×-1.2×25.8×+0.5×25.2×+0.5×
EV / EBITDA43.1×+0.4×42.7×-138×180.4×-34.7×215.1×-25.9×241×-27.2×
Dividend yield19.3%+0.1pp19.2%+0.4pp18.8%+0.9pp18%-0.5pp18.5%-0.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?
Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.